Centuple Global Ltd

NSE: RUBRAME · BSE: 531099 · Pharmaceuticals & Biotechnology · 21 announcements

Share price: ₹33.93
Market cap: ₹18.55 Cr
Revenue (annual): ₹573.8 Cr
Net profit (annual): ₹1.51 Cr
P/E (TTM): 15.0×Sector 47.4×
Promoter holding: 0.00%+0.00% QoQ
FII holding: 11.15%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 4 Board Meeting Date 4 Financial Results 3 Debt & Borrowing 2 Board Meeting Outcome 2 Annual General Meeting 2 Price Movement Clarification 1 Other Announcement 1 Legal & Regulatory 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

29 Apr 2026 16:14 IST BSE

Debt & Borrowing

Checkpoint Trends Debt & Borrowing: ₹6.73 Cr

Centuple Global Limited (formerly Checkpoint Trends Limited) disclosed that it is not a 'Large Corporate' as of March 31, 2026. The company reported outstanding borrowings of ₹6.73 Crore. This regulatory filing follows SEBI's debt-raising framework for large entities.

Value: ₹6.73 Cr

Read the filing ↗

29 Apr 2026 16:08 IST BSE

Debt & Borrowing

Checkpoint Trends Debt & Borrowing

Centuple Global Limited (formerly Checkpoint Trends Limited) submitted its annual disclosure for FY 2025-2026, confirming it does not meet the criteria for a 'Large Corporate' entity under SEBI norms. The company reported actual borrowings of ₹6.73 Crore through debt securities for the current block.

Read the filing ↗